Translational Development Acquisition Corp.
NASDAQ: TDAC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Michael Hoffman
- Employees
- 2
- Headquarters
- New York City, United States
- IPO year
- 2025
- Market cap
- $264.5M
- Website
- https://www.translational-development.com
Loading TDAC…
Loading profile data…Frequently asked questions about TDAC
What does Translational Development Acquisition Corp. (TDAC) do?
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Where does TDAC trade?
Translational Development Acquisition Corp. (TDAC) trades on the NASDAQ Capital Market.
What sector is TDAC in?
Translational Development Acquisition Corp. (TDAC) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Translational Development Acquisition Corp.?
Michael Hoffman is the chief executive officer of Translational Development Acquisition Corp. (TDAC).
Where is Translational Development Acquisition Corp. headquartered?
Translational Development Acquisition Corp. is headquartered in United States.
Does TDAC pay a dividend?
Translational Development Acquisition Corp. (TDAC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TDAC go public?
Translational Development Acquisition Corp. (TDAC) completed its initial public offering in 2025.